🔗 Permalink

Inventor profile of:

Dawei Chen

City:

Guilford, Connecticut

Country:

United States

Published Applications:

Last publication date:

2024-06-20

Top Assignees for applications by Dawei Chen

The entities that hold a legal rights for patent applications filed by inventor Chen Dawei:

Achillion Pharmaceuticals Inc. 48 New Haven, CT United States
Achillion Pharmaceuticals, Inc. 18 Boston, MA United States
JANSSEN PHARMACEUTICALS, INC. 3 Titusville, NJ United States
Achillion Pharmaceuticals, Inc. 2 Blue Bell, PA United States
ACHILLION PHARMACEUTICALS 1 New Haven, CT United States
Achillion Pharmaceutical, Inc. 1 New Haven, CT United States
Achillion Pharmaecuticals, Inc. 1 New Haven, CT United States

Recent patent applications by Chen Dawei

Dawei Chen from Guilford, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-06-20

US20240199583A1

Chemistry; metallurgy

ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS

#2 | 2024-02-22

US20240059702A1

Chemistry; metallurgy

Macrocyclic compounds for treatment of medical disorders

#3 | 2023-11-09

US20230357199A1

Chemistry; metallurgy

Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders

#4 | 2023-09-14

US20230287005A1

Chemistry; metallurgy

Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders

#5 | 2023-03-09

US20230071620A1

Chemistry; metallurgy

Pharmaceutical compounds for treatment of medical disorders

#6 | 2022-12-15

US20220396563A1

Chemistry; metallurgy

Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders

#7 | 2022-10-06

US20220315562A1

Chemistry; metallurgy

Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders

#8 | 2021-09-30

US20210300934A1

Chemistry; metallurgy

Macrocyclic compounds for treatment of medical disorders

#9 | 2021-09-02

US20210269458A1

Chemistry; metallurgy

ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS

#10 | 2021-04-29

US20210122733A1

Chemistry; metallurgy

Amino compounds for treatment of immune and inflammatory disorders

#11 | 2021-04-22

US20210115034A1

Chemistry; metallurgy

Amide compounds for treatment of immune and inflammatory disorders

#12 | 2020-08-20

US20200262818A1

Chemistry; metallurgy

Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders

#13 | 2020-03-05

US20200071301A1

Chemistry; metallurgy

Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders

#14 | 2020-02-27

US20200062790A1

Chemistry; metallurgy

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#15 | 2020-01-02

US20200002347A1

Chemistry; metallurgy

Macrocyclic compounds for treatment of medical disorders

#16 | 2019-12-19

US20190382376A1

Chemistry; metallurgy

Pharmaceutical compounds for treatment of medical disorders

#17 | 2019-07-11

US20190211033A1

Chemistry; metallurgy

Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders

#18 | 2019-06-20

US20190185498A1

Chemistry; metallurgy

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#19 | 2019-05-16

US20190144473A1

Chemistry; metallurgy

Amino compounds for treatment of complement mediated disorders

#20 | 2019-03-21

US20190085005A1

Chemistry; metallurgy

Phosphonate compounds for treatment of complement mediated disorders

#21 | 2019-02-14

US20190048033A1

Chemistry; metallurgy

Ether compounds for treatment of complement mediated disorders

#22 | 2019-01-31

US20190031692A1

Chemistry; metallurgy

Compounds for treatment of complement mediated disorders

#23 | 2019-01-24

US20190023729A1

Chemistry; metallurgy

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#24 | 2018-10-25

US20180305375A1

Chemistry; metallurgy

Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders

#25 | 2018-10-18

US20180298043A1

Chemistry; metallurgy

Alkyne Compounds for Treatment of Complement Mediated Disorders

#26 | 2018-10-11

US20180291047A1

Chemistry; metallurgy

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#27 | 2018-10-11

US20180291046A1

Chemistry; metallurgy

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#28 | 2018-07-19

US20180201580A1

Chemistry; metallurgy

Compounds for treatment of immune inflammatory disorders

#29 | 2018-07-05

US20180186782A1

Chemistry; metallurgy

Amide compounds for treatment of immune and inflammatory disorders

#30 | 2018-06-28

US20180179236A1

Chemistry; metallurgy

Disubstituted compounds for treatment of medical disorders

#31 | 2018-06-28

US20180179186A1

Chemistry; metallurgy

Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders

#32 | 2018-06-28

US20180179185A1

Chemistry; metallurgy

Amino compounds for treatment of immune and inflammatory disorders

#33 | 2018-06-28

US20180177761A1

Human necessities

Amino compounds for treatment of medical disorders

#34 | 2018-03-15

US20180072762A1

Chemistry; metallurgy

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#35 | 2018-02-01

US20180030075A1

Chemistry; metallurgy

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#36 | 2018-01-25

US20180022767A1

Chemistry; metallurgy

Compounds for treatment of complement mediated disorders

#37 | 2018-01-25

US20180022766A1

Chemistry; metallurgy

Ether compounds for treatment of complement mediated disorders

#38 | 2018-01-25

US20180021361A1

Human necessities

COMBINATION DRUG TREATMENT FOR HEPATITIS C INFECTION

#39 | 2018-01-25

US20180021360A1

Human necessities

Combination Therapy Regimen For Treatment Of Selected HCV Genotypes

#40 | 2017-11-09

US20170319572A1

Human necessities

COMBINATION DRUG TREATMENT FOR HEPATITIS C INFECTION

#41 | 2017-10-19

US20170298085A1

Chemistry; metallurgy

Carbamate, ester, and ketone compounds for treatment of complement mediated disorders

#42 | 2017-10-19

US20170298084A1

Chemistry; metallurgy

Amide compounds for treatment of complement mediated disorders

#43 | 2017-09-14

US20170260219A1

Chemistry; metallurgy

Phosphonate compounds for treatment of complement mediated disorders

#44 | 2017-07-06

US20170189410A1

Human necessities

Amino compounds for treatment of complement mediated disorders

#45 | 2017-03-30

US20170087174A1

Human necessities

COMBINATION THERAPY REGIMEN FOR TREATMENT OF HCV

#46 | 2017-03-09

US20170066783A1

Chemistry; metallurgy

Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders

#47 | 2017-03-02

US20170057993A1

Chemistry; metallurgy

Ether compounds for treatment of medical disorders

#48 | 2017-03-02

US20170057983A1

Chemistry; metallurgy

Phosphonate compounds for treatment of medical disorders

#49 | 2017-03-02

US20170057950A1

Chemistry; metallurgy

Amide compounds for treatment of medical disorders

#50 | 2017-03-02

US20170056428A1

Human necessities

Compounds for the treatment of medical disorders

#51 | 2016-12-15

US20160362433A1

Chemistry; metallurgy

ETHER COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#52 | 2016-12-15

US20160362432A1

Chemistry; metallurgy

PHOSPHONATE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#53 | 2016-12-15

US20160362399A1

Chemistry; metallurgy

ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#54 | 2016-12-15

US20160362398A1

Chemistry; metallurgy

Amide compounds for treatment of complement mediated disorders

#55 | 2016-12-15

US20160361329A1

Human necessities

COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#56 | 2015-08-27

US20150239921A1

Chemistry; metallurgy

Phosphonate compounds for treatment of complement mediated disorders

#57 | 2015-08-27

US20150239920A1

Chemistry; metallurgy

Ether compounds for treatment of complement mediated disorders

#58 | 2015-08-27

US20150239919A1

Chemistry; metallurgy

Carbamate, ester, and ketone compounds for treatment of complement mediated disorders

#59 | 2015-08-27

US20150239895A1

Chemistry; metallurgy

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#60 | 2015-08-27

US20150239894A1

Chemistry; metallurgy

Amino compounds for treatment of complement mediated disorders

#61 | 2015-08-27

US20150239893A1

Chemistry; metallurgy

Amide compounds for treatment of complement mediated disorders

#62 | 2015-08-27

US20150239868A1

Chemistry; metallurgy

Alkyne compounds for treatment of complement mediated disorders

#63 | 2015-08-27

US20150239838A1

Chemistry; metallurgy

Compounds for treatment of complement mediated disorders

InventorID:

1269140 ⎘